Premium
Oral Ciprofloxacin as Prophylaxis in Transurethral Resection of the Prostate
Author(s) -
MURDOCH D. A.,
BADENOCH D. F.,
GATCHALIAN E. R.
Publication year - 1987
Publication title -
british journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 0007-1331
DOI - 10.1111/j.1464-410x.1987.tb04953.x
Subject(s) - ciprofloxacin , transurethral resection of the prostate , medicine , prostate , urology , resection , antibiotic prophylaxis , surgery , antibiotics , microbiology and biotechnology , biology , cancer
Summary— A new quinolone antibacterial, ciprofloxacin, was evaluated as oral prophylaxis for transurethral resection of the prostate in a randomised controlled trial. A 3‐day course of peri‐operative ciprofloxacin 250 mg twice daily reduced the post‐operative infection rate, the post‐operative hospital stay and the frequency of infective complications. Ciprofloxacin was well tolerated and no significant haematological or biochemical side effects were detected.